🇺🇸 FDA
Pipeline program

GRoningen Early-PD Ambroxol Treatment Pharmacokinetics

GREAT-PK

Phase 1 other active

Quick answer

GRoningen Early-PD Ambroxol Treatment Pharmacokinetics for Parkinson's disease is a Phase 1 program (other) at Disc Medicine with 1 ClinicalTrials.gov record(s).

Program details

Company
Disc Medicine
Indication
Parkinson's disease
Phase
Phase 1
Modality
other
Status
active

Clinical trials